Gelonghui, December 6|Yisheng Pharmaceutical (002566.SZ) stated on the investor interactive platform that the company's product, erythromycin enteric tablets, can be used to treat mycoplasma pneumonia and chlamydia pneumonia.
益盛药业(002566.SZ)：产品红霉素肠溶片可用于治疗支原体肺炎和衣原体肺炎
Yisheng Pharmaceutical (002566.SZ): Product erythromycin enteric tablets can be used to treat mycoplasma pneumonia and chlamydia pneumonia
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.